LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article ; Online: Painful Chronic Ulcers on the Neck and Back.

    Erstine, Emily M / Collie, Angela M B / Piliang, Melissa P

    JAMA dermatology

    2016  Volume 152, Issue 12, Page(s) 1375–1376

    MeSH term(s) Back ; Biopsy ; Chronic Disease ; Diagnosis, Differential ; Granulomatosis with Polyangiitis/complications ; Granulomatosis with Polyangiitis/diagnosis ; Humans ; Male ; Middle Aged ; Neck ; Pain/diagnosis ; Pain/etiology ; Positron-Emission Tomography ; Skin/diagnostic imaging ; Tomography, X-Ray Computed ; Ulcer/complications ; Ulcer/diagnosis
    Language English
    Publishing date 2016-09-13
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2701761-8
    ISSN 2168-6084 ; 2168-6068
    ISSN (online) 2168-6084
    ISSN 2168-6068
    DOI 10.1001/jamadermatol.2016.3270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Testicular myeloid sarcoma: a rare manifestation of acute myeloid leukemia in an infant.

    Tran, Christine N / Collie, Angela M B / Flagg, Aron / Rhee, Audrey

    Urology

    2014  Volume 84, Issue 4, Page(s) 925–927

    Abstract: Myeloid sarcoma manifesting in the testis is rare and may occur concomitantly with bone marrow disease or as a separate entity. We describe our experience with a 6-month-old boy who presented with painless scrotal swelling and was found to have bilateral ...

    Abstract Myeloid sarcoma manifesting in the testis is rare and may occur concomitantly with bone marrow disease or as a separate entity. We describe our experience with a 6-month-old boy who presented with painless scrotal swelling and was found to have bilateral testicular masses on ultrasonography. The patient underwent unilateral radical inguinal orchiectomy. Surgical pathology revealed myeloid sarcoma of the testicle. He developed peripheral blood involvement 1 week postoperatively. Bone marrow biopsy showed acute myeloid leukemia. He is in remission after 2 cycles of induction chemotherapy, local radiation therapy, and allogeneic bone marrow transplantation.
    MeSH term(s) Humans ; Infant ; Leukemia, Myeloid, Acute/complications ; Leukemia, Myeloid, Acute/diagnosis ; Male ; Sarcoma, Myeloid/etiology ; Testicular Neoplasms/etiology
    Language English
    Publishing date 2014-10
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 192062-5
    ISSN 1527-9995 ; 0090-4295
    ISSN (online) 1527-9995
    ISSN 0090-4295
    DOI 10.1016/j.urology.2014.07.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cutaneous intravascular extramedullary hematopoiesis in a patient with post-polycythemia vera myelofibrosis.

    Collie, Angela M B / Uchin, Jeffrey M / Bergfeld, Wilma F / Billings, Steven D

    Journal of cutaneous pathology

    2013  Volume 40, Issue 7, Page(s) 615–620

    MeSH term(s) Aged ; Female ; Hematopoiesis, Extramedullary ; Humans ; Polycythemia Vera/complications ; Polycythemia Vera/pathology ; Primary Myelofibrosis/etiology ; Primary Myelofibrosis/pathology ; Skin/blood supply ; Skin/pathology
    Language English
    Publishing date 2013-07
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 187078-6
    ISSN 1600-0560 ; 0303-6987
    ISSN (online) 1600-0560
    ISSN 0303-6987
    DOI 10.1111/cup.12178
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Lobular neoplasia diagnosed on breast Core biopsy: frequency of carcinoma on excision and implications for management.

    Calhoun, Benjamin C / Collie, Angela M B / Lott-Limbach, Abberly A / Udoji, Esther N / Sieck, Leah R / Booth, Christine N / Downs-Kelly, Erinn

    Annals of diagnostic pathology

    2016  Volume 25, Page(s) 20–25

    Abstract: The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial. Several studies have attempted to address this issue, with ... ...

    Abstract The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial. Several studies have attempted to address this issue, with recommendations ranging from close clinical follow-up or surveillance to mandatory surgical excision in all cases. We report the findings at our institution, where virtually every core needle biopsy diagnosis of lobular neoplasia results in follow-up excision. The goal of the study was to identify potential predictors of upgrade to a more significant lesion. We identified 76 patients over a 15-year period with a core biopsy diagnosis of pure lobular neoplasia and no other high-risk lesions. Subsequent surgical excision identified 10 cases (13%) that were upgraded to carcinoma. Upgrade diagnoses included invasive ductal carcinoma (n=1), invasive lobular carcinoma (n=4), ductal carcinoma in situ (n=3), and pleomorphic lobular carcinoma in situ (n=2). All 10 upgraded cases had imaging findings suspicious for malignancy including irregular masses, asymmetric densities, or pleomorphic calcifications. Of the 10 upgraded cases, 7 were diagnosed as lobular carcinoma in situ on core biopsy. The data support a role for radiologic-pathologic correlation in the evaluation of suspicious breast lesions and suggest that the extent of lobular neoplasia in core biopsy specimens may be an indicator of the likelihood of upgrade to carcinoma.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Biopsy, Large-Core Needle/methods ; Breast Neoplasms/diagnosis ; Breast Neoplasms/pathology ; Carcinoma in Situ/pathology ; Carcinoma in Situ/therapy ; Carcinoma, Lobular/diagnosis ; Carcinoma, Lobular/pathology ; Female ; Humans ; Hyperplasia/diagnosis ; Hyperplasia/pathology ; Mammography ; Middle Aged ; Precancerous Conditions/pathology
    Language English
    Publishing date 2016-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1440011-x
    ISSN 1532-8198 ; 1092-9134
    ISSN (online) 1532-8198
    ISSN 1092-9134
    DOI 10.1016/j.anndiagpath.2016.07.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Differential monocyte/macrophage interleukin-1β production due to biomaterial topography requires the β2 integrin signaling pathway.

    Collie, Angela M B / Bota, Paige C S / Johns, Rachel E / Maier, Ronald V / Stayton, Patrick S

    Journal of biomedical materials research. Part A

    2011  Volume 96, Issue 1, Page(s) 162–169

    Abstract: ... factor kappa-B, another component of the β2 integrin signaling pathway, although it may not be ...

    Abstract Monocytes/macrophages are crucial mediators of the host response to biomaterials, and their level of activation can be directly affected by material characteristics. Previous work has demonstrated that primary human monocytes cultured on polytetrafluoroethylene materials of varying topography but identical surface chemistry are differentially affected. Monocytes/macrophages on biaxially-expanded polytetrafluoroethylene with an average intranodal distance of 4.4 μm (4.4-ePTFE) produced higher levels of the inflammatory cytokine interleukin-1 beta (IL-1β) compared with monocytes/macrophages on nonporous polytetrafluoroethylene (np-PTFE). The current study provides a mechanistic understanding of this response. Scanning electron microscopy revealed that monocytes/macrophages cultured on np-PTFE were more spread than those on 4.4-ePTFE. In addition, the actin cytoskeleton and intact β2 integrin receptors were necessary for IL-1β production by monocytes/macrophages on 4.4-ePTFE. This IL-1β production also required the transcription factor nuclear factor kappa-B, another component of the β2 integrin signaling pathway, although it may not be the primary transcription factor involved. These studies demonstrate the importance of several β2 integrin signaling components to the monocyte/macrophage response to biomaterial topography.
    MeSH term(s) CD18 Antigens/immunology ; Cell Shape ; Cells, Cultured ; Coated Materials, Biocompatible/chemistry ; Cytoskeleton/metabolism ; Humans ; I-kappa B Kinase/metabolism ; Interleukin-1beta/immunology ; Macrophages/cytology ; Macrophages/immunology ; Materials Testing ; Mitogen-Activated Protein Kinases/metabolism ; Monocytes/cytology ; Monocytes/immunology ; NF-kappa B/antagonists & inhibitors ; NF-kappa B/metabolism ; Signal Transduction/immunology ; Surface Properties
    Chemical Substances CD18 Antigens ; Coated Materials, Biocompatible ; IKBKG protein, human ; Interleukin-1beta ; NF-kappa B ; I-kappa B Kinase (EC 2.7.11.10) ; Mitogen-Activated Protein Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2011-01
    Publishing country United States
    Document type Evaluation Studies ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2099989-6
    ISSN 1552-4965 ; 1549-3296 ; 0021-9304
    ISSN (online) 1552-4965
    ISSN 1549-3296 ; 0021-9304
    DOI 10.1002/jbm.a.32963
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.

    Collie, Angela M B / Hill, Brian T / Stevens, Glen H J / Fenner, Kathleen / Gazdick, Elizabeth / Hsi, Eric D

    American journal of clinical pathology

    2014  Volume 141, Issue 4, Page(s) 515–521

    Abstract: Objectives: To identify pretest characteristics of cerebrospinal fluid (CSF) specimens that will allow the rational use of flow cytometric analysis (FCA) in the diagnosis of hematologic malignancy.: Methods: Retrospective data were collected on 501 ... ...

    Abstract Objectives: To identify pretest characteristics of cerebrospinal fluid (CSF) specimens that will allow the rational use of flow cytometric analysis (FCA) in the diagnosis of hematologic malignancy.
    Methods: Retrospective data were collected on 501 consecutive CSF samples submitted for FCA.
    Results: A positive diagnosis of hematologic malignancy was made in 41 specimens (8.2%). Blasts or atypical lymphocytes were noted on Wright-stained slides in 98% of FCA-positive specimens (40/41), and a history of a hematologic malignancy was present in 89% of specimens (34/38). All FCA-positive specimens had atypical morphology or history of hematologic malignancy. Four hundred six specimens (81%) were FCA negative. Of FCA-negative specimens, 7% (30/406) had atypical morphology, and 3% (12/404) had future central nervous system involvement seen within 30 days.
    Conclusions: These data support a policy in which FCA of CSF is actively discouraged unless atypical lymphocytes or blasts are seen or a history of hematologic malignancy is present.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Flow Cytometry ; Hematologic Neoplasms/cerebrospinal fluid ; Hematologic Neoplasms/pathology ; Humans ; Infant ; Leukemia/cerebrospinal fluid ; Leukemia/pathology ; Lymphoma/cerebrospinal fluid ; Lymphoma/pathology ; Male ; Middle Aged ; Retrospective Studies
    Language English
    Publishing date 2014-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2944-0
    ISSN 1943-7722 ; 0002-9173
    ISSN (online) 1943-7722
    ISSN 0002-9173
    DOI 10.1309/AJCP8IB8FRQDVPXL
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma.

    Clark Schneider, Kelli M / Banks, Peter M / Collie, Angela M B / Lanigan, Christopher P / Manilich, Elena / Durkin, Lisa M / Hill, Brian T / Hsi, Eric D

    Leukemia & lymphoma

    2015  Volume 57, Issue 7, Page(s) 1640–1648

    Abstract: ... of poor prognosis in diffuse large B-cell lymphoma. However, the immunohistochemistry protocols for dual ... expression staining and the scoring cut-offs vary by study. Sixty-nine cases of diffuse large B-cell lymphoma ... information in patients with de novo diffuse large B-cell lymphoma. This study has practical implications ...

    Abstract Recent studies suggested that MYC and BCL2 protein co-expression is an independent indicator of poor prognosis in diffuse large B-cell lymphoma. However, the immunohistochemistry protocols for dual-expression staining and the scoring cut-offs vary by study. Sixty-nine cases of diffuse large B-cell lymphoma were evaluated for MYC and BCL2 protein expression using various cut-offs that have been recommended in prior studies. Independent of the International Prognostic Index risk group, cases with dual protein expression of BCL2 and MYC using ≥50%/40% cut-offs and ≥70%/40% had significantly shorter overall survival than cases without. It was verified in this patient population that the use of BCL2 and MYC immunohistochemistry, performed with available in vitro diagnostic-cleared antibodies, provides rapid prognostic information in patients with de novo diffuse large B-cell lymphoma. This study has practical implications for diagnostic laboratories and serves as a guide for implementation in the setting of future clinical trials.
    MeSH term(s) Adult ; Aged ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Case-Control Studies ; Cyclophosphamide/therapeutic use ; Doxorubicin/therapeutic use ; Female ; Gene Expression ; Humans ; Immunohistochemistry ; Lymphoma, Large B-Cell, Diffuse/diagnosis ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/genetics ; Lymphoma, Large B-Cell, Diffuse/mortality ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Prednisone/therapeutic use ; Proportional Hazards Models ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Treatment Outcome ; Vincristine/therapeutic use
    Chemical Substances Antibodies, Monoclonal, Murine-Derived ; Proto-Oncogene Proteins c-bcl-2 ; Proto-Oncogene Proteins c-myc ; R-CHOP protocol ; Vincristine (5J49Q6B70F) ; Doxorubicin (80168379AG) ; Cyclophosphamide (8N3DW7272P) ; Prednisone (VB0R961HZT)
    Language English
    Publishing date 2015-12-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.3109/10428194.2015.1101099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.

    Harms, Paul W / Collie, Angela M B / Hovelson, Daniel H / Cani, Andi K / Verhaegen, Monique E / Patel, Rajiv M / Fullen, Douglas R / Omata, Kei / Dlugosz, Andrzej A / Tomlins, Scott A / Billings, Steven D

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

    2016  Volume 29, Issue 3, Page(s) 240–248

    Abstract: Merkel cell carcinoma is a rare but highly aggressive cutaneous neuroendocrine carcinoma. Cytokeratin 20 (CK20) is expressed in ~95% of Merkel cell carcinomas and is useful for distinction from morphologically similar entities including metastatic small- ... ...

    Abstract Merkel cell carcinoma is a rare but highly aggressive cutaneous neuroendocrine carcinoma. Cytokeratin 20 (CK20) is expressed in ~95% of Merkel cell carcinomas and is useful for distinction from morphologically similar entities including metastatic small-cell lung carcinoma. Lack of CK20 expression may make diagnosis of Merkel cell carcinoma more challenging, and has unknown biological significance. Approximately 80% of CK20-positive Merkel cell carcinomas are associated with the oncogenic Merkel cell polyomavirus. Merkel cell carcinomas lacking Merkel cell polyomavirus display distinct genetic changes from Merkel cell polyomavirus-positive Merkel cell carcinoma, including RB1 inactivating mutations. Unlike CK20-positive Merkel cell carcinoma, the majority of CK20-negative Merkel cell carcinomas are Merkel cell polyomavirus-negative, suggesting CK20-negative Merkel cell carcinomas predominantly arise through virus-independent pathway(s) and may harbor additional genetic differences from conventional Merkel cell carcinoma. Hence, we analyzed 15 CK20-negative Merkel cell carcinoma tumors (10 Merkel cell polyomavirus-negative, four Merkel cell polyomavirus-positive, and one undetermined) using the Ion Ampliseq Comprehensive Cancer Panel, which assesses copy number alterations and mutations in 409 cancer-relevant genes. Twelve tumors displayed prioritized high-level chromosomal gains or losses (average 1.9 per tumor). Non-synonymous high-confidence somatic mutations were detected in 14 tumors (average 11.9 per tumor). Assessing all somatic coding mutations, an ultraviolet-signature mutational profile was present, and more prevalent in Merkel cell polyomavirus-negative tumors. Recurrent deleterious tumor suppressor mutations affected TP53 (9/15, 60%), RB1 (3/15, 20%), and BAP1 (2/15, 13%). Oncogenic activating mutations included PIK3CA (3/15, 20%), AKT1 (1/15, 7%) and EZH2 (1/15, 7%). In conclusion, CK20-negative Merkel cell carcinoma display overlapping genetic changes with CK20-positive Merkel cell carcinoma, including RB1 mutations restricted to Merkel cell polyomavirus-negative tumors. However, some CK20-negative Merkel cell carcinomas harbor mutations not previously described in Merkel cell carcinoma. Hence, CK20-negative Merkel cell carcinomas harbor diverse oncogenic drivers which may represent therapeutic targets in individual tumors.
    MeSH term(s) Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Carcinoma, Merkel Cell/genetics ; DNA Mutational Analysis/methods ; Female ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Keratin-20/genetics ; Male ; Middle Aged ; Mutation ; Retinoblastoma Binding Proteins/genetics ; Skin Neoplasms/genetics ; Tumor Suppressor Protein p53/genetics ; Ubiquitin-Protein Ligases/genetics
    Chemical Substances Biomarkers, Tumor ; KRT20 protein, human ; Keratin-20 ; RB1 protein, human ; Retinoblastoma Binding Proteins ; TP53 protein, human ; Tumor Suppressor Protein p53 ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
    Language English
    Publishing date 2016-01-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 645073-8
    ISSN 1530-0285 ; 0893-3952
    ISSN (online) 1530-0285
    ISSN 0893-3952
    DOI 10.1038/modpathol.2015.154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.

    Collie, Angela M B / Nölling, Jörk / Divakar, Kiran M / Lin, Jeffrey J / Carver, Paula / Durkin, Lisa M / Hill, Brian T / Smith, Mitchell R / Radivoyevitch, Tomas / Kong, Lilly I / Daly, Thomas / Murugesan, Gurunathan / Guenther-Johnson, Jeanna / Dave, Sandeep S / Manilich, Elena A / Hsi, Eric D

    British journal of haematology

    2014  Volume 167, Issue 2, Page(s) 281–285

    MeSH term(s) Formaldehyde ; Gene Expression Profiling/methods ; Humans ; Lymphoma, Large B-Cell, Diffuse/classification ; Multiplex Polymerase Chain Reaction/methods ; Paraffin Embedding
    Chemical Substances Formaldehyde (1HG84L3525)
    Language English
    Publishing date 2014-06-25
    Publishing country England
    Document type Letter ; Research Support, N.I.H., Extramural
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.12983
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts.

    Wood, Greta K / Babar, Roshan / Ellul, Mark A / Thomas, Rhys Huw / Van Den Tooren, Harriet / Easton, Ava / Tharmaratnam, Kukatharmini / Burnside, Girvan / Alam, Ali M / Castell, Hannah / Boardman, Sarah / Collie, Ceryce / Facer, Bethany / Dunai, Cordelia / Defres, Sylviane / Granerod, Julia / Brown, David W G / Vincent, Angela / Marson, Anthony Guy /
    Irani, Sarosh R / Solomon, Tom / Michael, Benedict D

    BMJ neurology open

    2022  Volume 4, Issue 2, Page(s) e000323

    Abstract: Objective: In patients with encephalitis, the development of acute symptomatic seizures is highly variable, but when present is associated with a worse outcome. We aimed to determine the factors associated with seizures in encephalitis and develop a ... ...

    Abstract Objective: In patients with encephalitis, the development of acute symptomatic seizures is highly variable, but when present is associated with a worse outcome. We aimed to determine the factors associated with seizures in encephalitis and develop a clinical prediction model.
    Methods: We analysed 203 patients from 24 English hospitals (2005-2008) (Cohort 1). Outcome measures were seizures prior to and during admission, inpatient seizures and status epilepticus. A binary logistic regression risk model was converted to a clinical score and independently validated on an additional 233 patients from 31 UK hospitals (2013-2016) (Cohort 2).
    Results: In Cohort 1, 121 (60%) patients had a seizure including 103 (51%) with inpatient seizures. Admission Glasgow Coma Scale (GCS) ≤8/15 was predictive of subsequent inpatient seizures (OR (95% CI) 5.55 (2.10 to 14.64), p<0.001), including in those without a history of prior seizures at presentation (OR 6.57 (95% CI 1.37 to 31.5), p=0.025).A clinical model of overall seizure risk identified admission GCS along with aetiology (autoantibody-associated OR 11.99 (95% CI 2.09 to 68.86) and Herpes simplex virus 3.58 (95% CI 1.06 to 12.12)) (area under receiver operating characteristics curve (AUROC) =0.75 (95% CI 0.701 to 0.848), p<0.001). The same model was externally validated in Cohort 2 (AUROC=0.744 (95% CI 0.677 to 0.811), p<0.001). A clinical scoring system for stratifying inpatient seizure risk by decile demonstrated good discrimination using variables available on admission; age, GCS and fever (AUROC=0.716 (95% CI 0.634 to 0.798), p<0.001) and once probable aetiology established (AUROC=0.761 (95% CI 0.6840.839), p<0.001).
    Conclusion: Age, GCS, fever and aetiology can effectively stratify acute seizure risk in patients with encephalitis. These findings can support the development of targeted interventions and aid clinical trial design for antiseizure medication prophylaxis.
    Language English
    Publishing date 2022-09-05
    Publishing country England
    Document type Journal Article
    ISSN 2632-6140
    ISSN (online) 2632-6140
    DOI 10.1136/bmjno-2022-000323
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top